Cargando…

A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil

A retrospective cohort of 11,308 chronic hepatitis C infected patients treated with regimens that included Sofosbuvir (SOF), Daclatasvir (DCV), Simeprevir (SMV), or an association of Ombitasvir, Veruprevir/Ritonavir and Dasabuvir (3D) with or without Ribavirin (RBV) were assessed for sustained virol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vivaldini, Simone Monzani, Ribeiro, Rachel Abraão, Mosimann Júnior, Gláucio, Tonini, Karen Cristine, Pereira, Gerson Fernando Mendes, Araújo, Wildo Navegantes de
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392166/ https://www.ncbi.nlm.nih.gov/pubmed/33836175 http://dx.doi.org/10.1016/j.bjid.2021.101573

Ejemplares similares

Mortality Due to Chagas Disease in Brazil According to a Specific Cause
por: da Nóbrega, Aglaêr Alves, et al.
Publicado: (2014)

Effect of vaccination against Covid-19 one year after its introduction in Brazil
por: Percio, Jadher, et al.
Publicado: (2022)

Imputation method to reduce undetected severe acute respiratory infection cases during the coronavirus disease outbreak in Brazil
por: de Oliveira, Silvano Barbosa, et al.
Publicado: (2020)

Zika virus RNA surveillance in blood donors in the Federal District of Brazil during the 2016 outbreak
por: Slavov, Svetoslav Nanev, et al.
Publicado: (2020)

Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study
por: Pereira, Gustavo H., et al.
Publicado: (2022)

Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach
por: Benzaken, Adele Schwartz, et al.
Publicado: (2019)

The obscurance of the greatest sylvatic yellow fever epidemic and the cooperation of the Pan American Health Organization during the COVID-19 pandemic
por: Melo, Carlos Frederico Campelo de Albuquerque e, et al.
Publicado: (2020)

A systematic review of economic evaluations of interventions to tackle tuberculosis in homeless people
por: Silva, Everton Nunes, et al.
Publicado: (2018)

Outcomes of Zika virus infection during pregnancy: contributions to the debate on the efficiency of cohort studies
por: Duarte, Elisabeth Carmen, et al.
Publicado: (2017)

Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study
por: Lanini, Simone, et al.
Publicado: (2018)

Brazilian cohort study of risk factors associated with unsuccessful outcomes of drug resistant tuberculosis
por: Bartholomay, Patricia, et al.
Publicado: (2021)

Decline in reported AIDS cases in Brazil after implementation of the test and treat initiative
por: Pereira, Gerson Fernando Mendes, et al.
Publicado: (2019)

Seroprevalence of SARS-CoV-2 and Vaccination Coverage among Residents of a Lower-Middle-Class Population in the Federal District, Brazil
por: Nogueira de Brito, Raíssa, et al.
Publicado: (2023)

Clinical outcomes of DAA and related techniques in hip arthroplasty
por: Driesman, Adam, et al.
Publicado: (2023)

Outbreak caused by the SARS-CoV-2 Omicron variant in the psychiatric ward of a general hospital in Brazil
por: Vanni, Tazio, et al.
Publicado: (2022)

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
por: Maughan, A., et al.
Publicado: (2019)

Wide distribution of Trypanosoma cruzi-infected triatomines in the State of Bahia, Brazil
por: Ribeiro, Gilmar, et al.
Publicado: (2019)

Treatment of hepatitis C in HIV patients in the new DAA era
por: Soriano, Vicente
Publicado: (2014)

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs
por: Paolucci, Stefania, et al.
Publicado: (2017)

Is DAA Treatment Associated with HBV Reactivation? Results from ERCHIVES
por: Butt, Adeel, et al.
Publicado: (2017)

Treatment of hepatitis C virus genotype 4 in the DAA era
por: Di Biagio, Antonio, et al.
Publicado: (2018)

Treatment and re-treatment results of HCV patients in the DAA era
por: Piecha, Felix, et al.
Publicado: (2020)

Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure
por: Danishwar, Mahmood, et al.
Publicado: (2022)

Evidence of co-circulation of multiple arboviruses transmitted by Aedes species based on laboratory syndromic surveillance at a health unit in a slum of the Federal District, Brazil
por: Rufalco-Moutinho, Paulo, et al.
Publicado: (2021)

Dengue seroprevalence among asymptomatic blood donors during an epidemic outbreak in Central-West Brazil
por: Slavov, Svetoslav Nanev, et al.
Publicado: (2019)

Public policies on sexually transmitted infections in Brazil
por: Miranda, Angélica Espinosa, et al.
Publicado: (2021)

Transitioning from antenatal surveillance surveys to routine HIV testing: a turning point in the mother-to-child transmission prevention programme for HIV surveillance in Brazil
por: Pereira, Gerson Fernando Mendes, et al.
Publicado: (2017)

Laboratory-based study of drug resistance and genotypic profile of multidrug-resistant tuberculosis isolates in Salvador, Bahia, Brazil
por: Sousa, Erivelton de Oliveira, et al.
Publicado: (2022)

Environmental spreading of clinically relevant carbapenem-resistant gram-negative bacilli: the occurrence of bla(KPC-or-NDM) strains relates to local hospital activities
por: Pereira, Alex Leite, et al.
Publicado: (2022)

Direct costs of prematurity and factors associated with birth and maternal conditions
por: de Melo, Thamires Francelino Mendonça, et al.
Publicado: (2022)

Updated View on Kidney Transplant from HCV-Infected Donors and DAAs
por: Fabrizi, Fabrizio, et al.
Publicado: (2021)

Changing Landscape of Liver Transplantation in the Post-DAA and Contemporary ART Era
por: Saeed, Huma, et al.
Publicado: (2022)

The effect of APN, hs-CRP and APN/hs-CRP in periodontitis with DAA
por: Cheng, Rui, et al.
Publicado: (2023)

Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients
por: Ménard, A, et al.
Publicado: (2014)

Efficacy of DAAs in the Treatment of Chronic HCV: Real-World Data from the Private Health-Care Sector of the Kingdom of Saudi Arabia
por: Hashim, Almoutaz, et al.
Publicado: (2020)

Identifying socioeconomic, epidemiological and operational scenarios for tuberculosis control in Brazil: an ecological study
por: Pelissari, Daniele Maria, et al.
Publicado: (2018)

Oral Transmission of Chagas Disease by Consumption of Açaí Palm Fruit, Brazil
por: Nóbrega, Aglaêr A., et al.
Publicado: (2009)

Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis
por: Mangia, Alessandra, et al.
Publicado: (2018)

Linkage and retention in HCV care for HIV‐infected populations: early data from the DAA era
por: Sacks‐Davis, Rachel, et al.
Publicado: (2018)

Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of the Implementation of Public Health Policies on HTLV-1 in Brazil
por: Miranda, Angelica Espinosa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vf2ro3gveemctgnlq1bv1bbe90